Caladrius Biosciences Closes The Sale Of Its Remaining Interest In PCT To Hitachi Chemical Co., Ltd. For $75 Million Post author:Sam Post published:May 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Spark, Pfizer's Gene Therapy Hemophilia B Drug Stuns in Trial December 6, 2017 Cellectis CEO Provides Update on UCART Programs and ‘Laser Focus’ of Company in 2018 January 24, 2018 15 In-Demand Life Science Jobs in Northern California June 21, 2017
Cellectis CEO Provides Update on UCART Programs and ‘Laser Focus’ of Company in 2018 January 24, 2018